Home > Cashflow Statement > CONCORD BIOTECH

CONCORD BIOTECH
Cash Flow from Operating Activities

    Back to Cashflow Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Operating Activities ₹265 Cr₹246 Cr₹207 Cr₹167 Cr₹155 Cr

What is the latest Cash Flow from Operating Activities ratio of CONCORD BIOTECH ?

The latest Cash Flow from Operating Activities ratio of CONCORD BIOTECH is ₹265 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Operating Activities
Mar2024₹265 Cr
Mar2023₹246 Cr
Mar2022₹207 Cr
Mar2021₹167 Cr
Mar2020₹155 Cr

How is Cash Flow from Operating Activities of CONCORD BIOTECH Trending?

Years Cash Flow from Operating Activities % Change
Mar2024 ₹265 Cr
7.91
Mar2023 ₹246 Cr
18.57
Mar2022 ₹207 Cr
24.37
Mar2021 ₹167 Cr
7.76
Mar2020 ₹155 Cr -

Compare Cash Flow from Operating Activities of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹17,231.8 Cr -5.3% -29.7% 20.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,246.0 Cr 4.7% -5.4% 0.5% Stock Analytics
DIVIS LABORATORIES ₹147,119.0 Cr 0.5% -9.8% 55.5% Stock Analytics
CIPLA ₹116,805.0 Cr 2% -1.8% -1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹103,554.0 Cr 2.6% -6.1% 14% Stock Analytics
DR REDDYS LABORATORIES ₹93,192.0 Cr -0.9% -10% -11.3% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-5.3%

-29.7%

20.5%

SENSEX

1.5%

-5.1%

0.6%


You may also like the below Video Courses